BLOC1S1 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Jurkat human T lymphocyte line. This product consists of a genetically heterogeneous pool of cells harboring targeted disruptions in the BLOC1S1 gene, which encodes a subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1). The polyclonal format provides a population-level loss-of-function model that avoids clonal biases and is well-suited for robust biochemical and cell biological analyses of endosomal sorting and lysosome-related organelle biology.
Jurkat cells are an immortalized human T cell leukemia-derived line extensively utilized to study T cell signaling, apoptosis, and HIV infection. Their well-characterized hematopoietic origin and ease of genetic manipulation make them an adaptable host for investigating intracellular trafficking pathways. In this model, the knockout of BLOC1S1 allows researchers to dissect the role of the BLOC-1 complex in a physiologically relevant immune cell context, where endosomal sorting contributes to processes such as receptor recycling and secretory lysosome function.
BLOC1S1 functions as a obligate subunit of the BLOC-1 complex, which mediates cargo sorting from early endosomes to lysosome-related organelles. The complex interacts with adaptor proteins AP-1 and AP-3, clathrin, Rab7, Rab9, VAMP7, and syntaxin 13 to direct the trafficking of downstream targets including tyrosinase, LAMP-1, and platelet dense granule components. Disruption of BLOC1S1 impairs AP-3-dependent cargo delivery, leading to defective melanosome maturation and platelet biogenesis. Although upstream regulation is not fully elucidated, the BLOC-1 complex may be influenced by TFEB-mediated lysosomal gene expression programs. Consequently, this knockout recapitulates trafficking defects observed in Hermansky-Pudlak syndrome type 9.
Within the Jurkat T cell background, BLOC1S1 loss perturbs endosomal protein sorting pathways that may affect immune receptor trafficking, cytokine secretion, or lytic granule biogenesis??processes essential for adaptive immune responses. This model thus offers a powerful system to explore how lysosome-related organelle dysfunctions impact T lymphocyte physiology. It provides a platform to bridge molecular trafficking defects with cellular immunological phenotypes, potentially uncovering mechanistic links to the immune dysregulation reported in Hermansky-Pudlak syndrome.
These polyclonal knockout cells are suitable for a broad range of research applications, including western blotting to verify BLOC1S1 ablation, immunofluorescence and confocal microscopy to examine LAMP-1 or tyrosinase mislocalization, co-immunoprecipitation to assess BLOC-1 complex assembly, and vesicle trafficking pulse-chase experiments. Flow cytometric analysis of surface receptors can be used to evaluate endocytic recycling perturbations. The cells enable detailed studies of endosomal sorting mechanisms, serve as a model for Hermansky-Pudlak syndrome, and facilitate drug screening for compounds that correct lysosomal trafficking defects. For additional information or to discuss custom applications, please contact Ascent Research.
